You feel fine. The stent did its job, the chest pain has gone, and you are back to normal life — so it can be jarring to apply for life insurance after a heart stent and be met with a long cardiac questionnaire and, often, a wait before any price appears. The reason is not that the insurer doubts you feel well. It is that a stent is a treatment for coronary artery disease, and to an underwriter the fact that an artery needed fixing is itself the risk marker, whatever your symptoms are like now.

That is the pivot the whole assessment turns on, and it is worth sitting with for a moment. The procedure that made you feel better is, from an insurance point of view, evidence that the disease was there and significant enough to treat. Feeling fine afterwards is genuinely good, and it does count — but it is read as recovery from a known event, not as the absence of one. Understanding that flips the questionnaire from something that feels unfair into something that makes sense.

What follows walks through what the cardiac questionnaire actually asks, why insurers so often postpone before they price, and what a good recovery is and is not worth when the terms are set.

At a glance

  • A stent treats coronary artery disease; the need for one is the risk marker, so feeling well does not remove the history.
  • Expect a cardiac questionnaire covering the date and reason, vessels treated, ejection fraction, current symptoms, blood pressure, cholesterol, medication, smoking and cardiac rehab.
  • Insurers commonly postpone for a period after the procedure so recovery and follow-up are complete. Applying too early usually produces a postponement, not a price.
  • A stent after a heart attack is generally read more cautiously than a planned, elective one.
  • A good recovery shapes the terms rather than removing the history, and insurers differ, so one answer is not the market.

The short answer: a fix reads as a risk marker

When an underwriter sees that you have had a coronary stent, the first thing it tells them is not "this person is well now" but "this person has coronary artery disease significant enough to need intervention." Both things can be true at once, and the insurer holds them together. Your current wellbeing is part of the assessment; the underlying disease is the other part, and it does not disappear because a narrowed artery has been propped open.

This is why the questionnaire is detailed and why the answer is rarely instant. The insurer is trying to build a picture of how extensive the disease was, how well your heart is working now, how well the risk factors behind it are controlled, and whether anything has happened since. None of that can be read from the single fact of a stent, so it asks — question by question — for the detail that lets it judge the risk.

Why a successful stent still reads as a risk marker

Coronary heart disease remains one of the most common causes of death in the United Kingdom, which is the backdrop against which every cardiac application is read. A stent addresses a specific narrowing; it does not cure the wider tendency of the arteries to fur and narrow, and that tendency is what an underwriter is pricing. So a technically perfect procedure that leaves you symptom-free is excellent news clinically and still leaves a disclosable cardiac history behind it.

Source: British Heart Foundation, UK Cardiovascular Disease Factsheet.

It helps to separate the two questions the insurer is really asking. The first is about the event and the disease: how much of your heart's blood supply was affected, and how much muscle, if any, was damaged. The second is about the future: how well the risk factors that caused the narrowing — blood pressure, cholesterol, smoking, diabetes, weight — are now controlled. A stent answers neither of those on its own, which is precisely why the questionnaire exists.

Why insurers postpone before they price

One of the most common and most misread outcomes after a stent is a postponement: the insurer declines to quote yet and asks you to come back after a stated period. This is not a refusal of cover and it is not a judgement on you. It is the insurer saying that too much is still unsettled to price the risk fairly — recovery is ongoing, follow-up investigations may not be complete, medication may still be being adjusted, and a further procedure is not yet ruled out.

Applying in the first weeks or months, when all of that is still in flux, therefore tends to produce a wait rather than a number. The postponement period varies by insurer, and by whether the stent followed a heart attack or a planned investigation. The practical lesson is that timing matters: an application made once your recovery has settled, your follow-up is done and your medication is stable is far more likely to yield actual terms than one made while everything is still moving. If you do receive a postponement, read it as a timetable, a point we set out more fully in why being postponed for twelve months is not a decline.

The cardiac questionnaire, question by question

The cardiac supplement looks intimidating, but each question is there for a reason, and knowing what each one is getting at lets you answer it well and gather the right evidence beforehand.

The date and reason for the procedure

When it happened and why — a planned response to an abnormal test, or an emergency after symptoms — sets the timeline and tells the underwriter which postponement period applies and how far into recovery you are.

How many vessels were treated

Single-vessel disease treated with one stent is a different picture from multi-vessel disease needing several. The number and location of the arteries treated indicate how extensive the coronary disease was.

Whether you had a heart attack

A stent placed after a heart attack means heart muscle may have been damaged, which the underwriter weighs differently from an elective stent placed before any damage occurred. This is often the single most influential answer on the form.

Your ejection fraction

This is the measure, usually from an echocardiogram, of how well your heart pumps with each beat. It is one of the most important numbers in the whole assessment, because it shows how much pumping function was preserved. If you have had an echo, the report will contain it, and it is worth having to hand.

Current symptoms

Ongoing chest pain, breathlessness or angina since the stent point to disease that is not fully controlled. Being genuinely symptom-free is one of the more helpful things you can report, and it is a question worth answering precisely rather than optimistically.

Blood pressure, cholesterol, medication and smoking

These are the controllable risk factors behind coronary disease. Well-controlled blood pressure and cholesterol, a stable medication regime, and — if you smoked — evidence that you have stopped, all tell the underwriter the drivers of the disease are being managed. Smoking status after a cardiac event carries particular weight.

Whether you completed cardiac rehabilitation

Finishing a cardiac rehab programme is read as a positive sign: it indicates structured recovery and engagement with the risk factors that matter. It is a small thing to be able to say yes to, and it helps.

A planned stent versus one after a heart attack

The distinction between an elective stent and one placed in the aftermath of a heart attack runs through the whole assessment, so it is worth understanding on its own. An elective, or planned, stent is fitted after an investigation finds a narrowing that is best treated before it causes an event. In that case there may be no damage to the heart muscle at all, and the ejection fraction may be entirely normal.

A stent placed during or immediately after a heart attack is different, because by then some heart muscle may already have been starved of blood and damaged. That potential damage — reflected in the ejection fraction and in any ongoing symptoms — is what leads underwriters to read a post-heart-attack stent more cautiously than a planned one, even when the person feels equally well. Neither situation is a barrier to cover in itself; they simply sit at different points on the scale the underwriter is using, and they explain why two people who both "had a stent" can be offered quite different terms.

What a good recovery is worth, and shopping the market

A strong recovery genuinely helps, but it is worth being clear about what it does. Stable symptoms, controlled blood pressure and cholesterol, no further cardiac events, completed rehab and, where relevant, stopping smoking all sit alongside the original event and shape the terms you are offered. What they do not do is erase the history: the stent and the disease behind it remain disclosable facts, and the terms reflect both the event and your recovery from it.

Because insurers weigh cardiac histories differently, one insurer's answer is not the market's. A rating or a postponement from one is a reason to look wider, ideally through a broker who places cardiac cases and can present your ejection fraction, your rehab and your risk-factor control properly. Part of that process is often a nurse screening, where fresh readings are taken, and knowing what actually happens at a nurse screening takes some of the anxiety out of it. If a decline does come back, it is also worth understanding whether that decision could affect later applications, which we cover in whether a life insurance decline sits on a shared database.

Cardiac risk also travels with related vascular histories, so if you have had a warning of a different kind, our companion piece on applying after a transient ischaemic attack covers the same terrain from the stroke-risk side. And if a heart event has prompted low mood — not unusual after a scare — an antidepressant is underwritten on its own terms, as set out in applying while you are on an antidepressant. When you are ready to see where you stand, you can get life insurance quotes and have an FCA-authorised broker work from your actual cardiac history rather than a worst case.

Scotland and Northern Ireland

Cardiac care and cardiac rehabilitation are provided across the United Kingdom, organised through NHS Scotland, NHS Wales and Health and Social Care in Northern Ireland as well as NHS England, so your follow-up and your rehab evidence will come from your own nation's services. The underwriting itself works the same way wherever you live: the same cardiac questionnaire, the same postponement logic, the same weighing of ejection fraction and risk-factor control.

One background difference is worth knowing. Where an insurer asks your GP or cardiologist for a report, the consent framework in England, Wales and Scotland is the Access to Medical Reports Act 1988, while Northern Ireland uses the Access to Personal Files and Medical Reports (Northern Ireland) Order 1991. In each case you can ask to see a report from your own doctor before it is sent to the insurer, which is worth doing if your cardiac history is complex and you want to check it reads accurately.

Frequently asked questions

How long after a stent will insurers consider an application?

Most insurers postpone for a period after the procedure so that recovery, follow-up investigations and any further treatment are complete. The wait varies by insurer, and by whether the stent followed a heart attack or a planned investigation. Applying too early usually produces a postponement, not a price.

What does the cardiac questionnaire ask for?

Typically the date and reason for the procedure, how many vessels were treated, whether you had a heart attack, your ejection fraction, current symptoms such as chest pain or breathlessness, blood pressure and cholesterol readings, your medication, smoking status, and whether you completed cardiac rehabilitation.

Does a good recovery help my application?

It is part of the picture. Underwriters look for stable symptoms, controlled blood pressure and cholesterol, no further cardiac events, and evidence you have stopped smoking if you did. Those factors sit alongside the original event, so they shape the terms offered rather than removing the history.